ArticleThe pharmacogenomics journal2016

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis.

M Fabris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.